Cefaclor
Back to searchMolecule Structure
Scientific Name
Cefaclor
Description of the Drug
Cefaclor is a second generation cephalosporin used to treat a wide variety of infections in the body.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00833
http://www.drugbank.ca/drugs/DB00833
Brand Name(s)
Ceclor, Raniclor
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Dava Pharmaceuticals Inc, Heritage Pharma Labs Inc, Ranbaxy Pharmaceuticals Inc, Watson Laboratories Inc, Ceph International Corp, Eli Lilly And Co, Yung Shin Pharmaceutical Industrial Co Ltd, Facta Farmaceutici Spa, World Gen Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial penicillin-binding protein | PROTEIN FAMILY | INHIBITOR | CHEMBL2354204 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL33540 | |
| Human Metabolome Database | HMDB0014971 | |
| DrugBank | DB00833 | |
| PubChem: Thomson Pharma | 14803830 | 14852885 |
| PubChem | 51039 | 7048572 |
| LINCS | LSM-5368 | |
| Nikkaji | J3.196H | |
| BindingDB | 42131 | |
| EPA CompTox Dashboard | DTXSID3022748 | |
| DrugCentral | 525 | |
| Brenda | 88326 | 2601 |
| ChemicalBook | CB9390436 | |
| rxnorm | CEFACLOR ANHYDROUS | CEFACLOR |
| PubChem: Drugs of the Future | 12013565 | |
| KEGG Ligand | C06877 | |
| ChEBI | 3478 | |
| ZINC | ZINC000003812869 |
